My question is on the diagnostic business. So last quarter, you have mentioned that we are done with rebranding exercises and these expenses will taper off in the end of FY '25. So we will not see any rebranding costs in the coming quarter or is there any carryover? And one more question is on the variance of the margins in the diagnostic business. Revenu e Q-o-Q, if we see, it's flat, but there is 2.1% variance in the margin. So, what is driving this? Just one more question is on the BG Road expansion on hospitals, how many beds are we expecting in FY '26?
Questions across 1 call
Deepthi Rajulapati
Axis AMC